Viking Therapeutics, Inc.
VKTX
$33.80
-$0.64-1.86%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 501.66M | 602.96M | 705.74M | 714.57M | 807.72M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 941.00K | 1.22M | 1.81M | 2.24M | 2.82M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 14.96M | 4.02M | 8.05M | 21.89M | 16.48M |
| Total Current Assets | 517.56M | 608.21M | 715.60M | 738.70M | 827.02M |
|
|
|||||
| Total Current Assets | 517.56M | 608.21M | 715.60M | 738.70M | 827.02M |
| Net Property, Plant & Equipment | 4.01M | -- | 85.00K | 666.00K | 780.00K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 324.00K | 33.00K | 46.00K | 46.00K | 54.00K |
| Total Assets | 521.90M | 608.24M | 715.73M | 739.42M | 827.85M |
|
|
|||||
| Total Accounts Payable | 69.01M | 67.18M | 53.25M | 4.41M | 5.49M |
| Total Accrued Expenses | 40.48M | 39.14M | 23.28M | 21.22M | 26.02M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 161.00K | -- | 137.00K | 437.00K | 468.00K |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 109.66M | 106.33M | 76.67M | 26.07M | 31.98M |
|
|
|||||
| Total Current Liabilities | 109.66M | 106.33M | 76.67M | 26.07M | 31.98M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 3.93M | -- | -- | 318.00K | 410.00K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 113.58M | 106.33M | 76.67M | 26.39M | 32.39M |
|
|
|||||
| Common Stock & APIC | 1.54B | 1.51B | 1.49B | 1.40B | 1.39B |
| Retained Earnings | -1.13B | -1.01B | -847.55M | -689.88M | -599.10M |
| Treasury Stock & Other | -1.15M | -856.00K | 378.00K | 374.00K | -166.00K |
| Total Common Equity | 408.32M | 501.92M | 639.06M | 713.03M | 795.46M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 408.32M | 501.92M | 639.06M | 713.03M | 795.46M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 408.32M | 501.92M | 639.06M | 713.03M | 795.46M |
|
|
|||||